Explore how a growing understanding of B-cell biology is reshaping treatment strategies in MG and NMOSD, with increasing attention to earlier use of targeted therapies.
Navigating the Evolving Role of B-Cell Therapies in Myasthenia Gravis and Neuromyelitis Optica Spectrum Disorder
Explore how a growing understanding of B-cell biology is reshaping treatment strategies in MG and NMOSD, with increasing attention to earlier use of targeted therapies.
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Grants Fast Track Designation to Safusidenib for IDH1-Mutant Glioma
2
FDA Clears Roche's Single-Biomarker Elecsys pTau217 Blood Test for Alzheimer Disease
3
The Future of Targeted Therapy in CIDP
4
Early Diagnosis, Multidisciplinary Care Redefine the SMA Treatment Journey
5